Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system

The receptor binding domain (RBD) plays a pivotal role in the viral entry as it enables the engagement of severe acute respiratory syndrome 2 (SARS-CoV-2) with the human angiotensin-converting enzyme 2 (ACE2) receptor for host cell entry. RBD is the major target for developing viral inhibitors and v...

Descripción completa

Detalles Bibliográficos
Autores principales: Darvish, Maliheh, Moosavi-Nejad, Zahra, Siadat, Seyed Omid Ranaei, Fatemi, Fataneh, Khatibi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867563/
https://www.ncbi.nlm.nih.gov/pubmed/36693449
http://dx.doi.org/10.1016/j.virusres.2023.199047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867563/
https://www.ncbi.nlm.nih.gov/pubmed/36693449
http://dx.doi.org/10.1016/j.virusres.2023.199047

Ejemplares similares